idUS
Depósito de Investigación
Universidad de Sevilla
| | | BUS |
  • Español
Login | Contact | Help | Biblioteca USBUS |
  • Español
 
JavaScript is disabled for your browser. Some features of this site may not work without it.
All of idUSCommunities and CollectionsBy Issue DateAuthorsTitlesSubjectsFunding agenciesAward-winning thesesAuthor profiles USThis CollectionBy Issue DateAuthorsTitlesSubjectsFunding agencies
My AccountLoginRegisterDeposit your workApplication to deposit in idUSRequest the deposit to the LibraryMore info
Author
Pascual Hernández, Álvaro (33)
Rodríguez-Baño, Jesús (30)Martínez-Martínez, Luis (12)López Cerero, Lorena (9)Pachón Díaz, Jerónimo (9)Bou, Germán (8)Cisneros, José Miguel (7)Fernández-Cuenca, Felipe (6)Vila, Jordi (6)Gutiérrez Gutiérrez, Belén (5)... View MoreSubjectEscherichia coli (8)Antibacterianos (4)Fosfomycin (3)ST131 (3)Aminoglycosides (2)Beta-Lactamasas (2)Epidemiología molecular (2)ESBL (2)Extended-spectrum β-lactamases (2)Infecciones por escherichia coli (2)... View MoreDate Issued2020 - 2022 (12)2010 - 2019 (16)2004 - 2009 (5)Funding agencyEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER) (3)Junta de Andalucía (3)Instituto de Salud Carlos III (2)Ministerio de Ciencia, Innovación y Universidades (MICINN). España (2)Ministerio de Economia, Industria y Competitividad (MINECO). España (2)Ministerio de Economía y Competitividad (MINECO). España (2)European Regional Development Fund 'A way to achieve Europe', Operative program Intelligent Growth 2014-2020 (1)Fondo de Investigación Sanitaria (1)Innovative Medicines Initiative (IMI) (1)Instituto Carlos III , PS09/00916 (1)... View More
PoliciesInstitutional statementBerlin DeclarationidUS Policies
Recolecta
LA ReferenciaOpenAIRE
HispanaEuropeana
Google AcadémicoBase
OAIsterCORE
DART-Europe E-theses PortalOpenDOAR
re3data.orgfairsharing.org
 
Search 
  •   idUS
  • Investigación
  • Ciencias de la Salud
  • Medicina
  • Artículos (Medicina)
  • Search
  •   idUS
  • Investigación
  • Ciencias de la Salud
  • Medicina
  • Artículos (Medicina)
  • Search

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 33

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Article
Icon

Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-B-Lactamase- Producing Escherichia coli 

Retamar Gentil, Pilar; López Cerero, Lorena; Muniain Ezcurra, Miguel Angel; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús (American Society for Microbiology, 2013-07)
We investigated the impact of the piperacillin-tazobactam MIC in the outcome of 39 bloodstream infections due to extended- spectrum-B-lactamase-producing Escherichia coli. All 11 patients with urinary tract infections ...
Article
Icon

Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients 

Rodríguez-Baño, Jesús; Dolores Navarro, María; Romero, Luisa; Martínez-Martínez, Luis; Muniain Ezcurra, Miguel Angel; Perea J., Evelio; Pérez Cano, Ramón; Pascual Hernández, Álvaro (American Society for Microbiology, 2004-03)
Infections due to extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBLEC) in nonhospitalize patients seem to be emerging in different countries. Their incidence, epidemiology, and clinical impact in the ...
Article
Icon

Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients 

Gutiérrez Gutiérrez, Belén; Pérez-Nadales, Elena; Pérez-Galera, Salvador; Cordero Matia, María Elisa; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús (American Society Microbiology, 2021)
There are scarce data on the efficacy of ertapenem in the treatment of bacteremia due to extended-spectrum-beta-lactamase (ESBL)-producing Enterobacterales (ESBL-E) in kidney transplant (KT) recipients. We evaluated the ...
Article
Icon

Type 1 Integrons in Epidemiologically Unrelated Acinetobacter baumannii Isolates Collected at Spanish Hospitals 

Ribera, Anna; Vila, Jordi; Fernández-Cuenca, Felipe; Martínez-Martínez, Luis; Pascual Hernández, Álvaro; Beceiro Casas, Alejandro; Bou, Germán; Cisneros, José Miguel; Pachón Díaz, Jerónimo; Rodríguez-Baño, Jesús (American Society for Microbiology, 2004-01)
Article
Icon

Epidemiological and Clinical Complexity of Amoxicillin-Clavulanate- Resistant Escherichia coli 

Rodríguez-Baño, Jesús; Oteo, Jesús; Ortega, Adriana; Villar, Macarena; Conejo Gonzalo, Mª Carmen; Bou, Germán; Aranzamendi-Zaldumbide, Maitane; Cercenado, Emilia; Gurguí, Mercè; Martínez-Martínez, Luis; Merino, María; Rivera, Alba; Oliver, Antonio; Weber, Irene; Pascual Hernández, Álvaro; Bartolomé, Rosa M.; Gónzalez López, Juan José; Campos, José (American Society for Microbiology, 2013-07)
Two hundred twelve patients with colonization/infection due to amoxicillin-clavulanate (AMC)-resistant Escherichia coli were studied. OXA-1- and inhibitor-resistant TEM (IRT)-producing strains were associated with urinary ...
Article
Icon

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections A Randomized Clinical Trial 

Sojo Dorado, Jesús; López Hernández, Inmaculada; Rosso Fernández, Clara; Morales, Isabel; Palacios-Baena, Zaira R.; Hernández Torres, Alicia; Lobo Acosta, María Ángeles; Merino Bohórquez, Vicente; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús; Retamar Gentil, Pilar (Jama Nerwork Open, 2022)
Importance The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected ...
Article
Icon

Intestinal colonization due to Escherichia coli ST131: Risk factors and prevalence 

Morales Barroso, Isabel; López Cerero, Lorena; Navarro, María Dolores; Gutiérrez Gutiérrez, Belén; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús (Biomed Central, 2018-11-15)
Background Escherichia coli sequence type 131 (ST131) is a successful clonal group that has dramatically spread during the last decades and is considered an important driver for the rapid increase of quinolone resistance ...
Article
Icon

Prevalence, Incidence, and Risk Factors for Intestinal Colonization Due to Fluoroquinolone-Resistant ST131 Escherichia coli: a Longitudinal Study in Highly Dependent, Long-Term Care Facility Residents 

Salamanca Rivera, Elena; López Cerero, Lorena; Rodríguez Martínez, José Manuel; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús (American Society for Microbiology, 2022)
Escherichia coli ST131 clade C is an important driver for fluoroquinolone resistance (FQ-R). We conducted a prospective observational study in residents from two long-term care facilities (LTCFs) in Seville, Spain, in 2018. ...
Article
Icon

Clinical Features of Infections and Colonization by Acinetobacter Genospecies 3 

Molina, José; Cisneros, José Miguel; Fernández-Cuenca, Felipe; Rodríguez-Baño, Jesús; Ribera, Anna; Beceiro Casas, Alejandro; Martínez-Martínez, Luis; Pascual Hernández, Álvaro; Bou, Germán; Vila, Jordi; Pachón Díaz, Jerónimo (American Society for Microbiology, 2010-12)
Two hundred twenty-one isolates of Acinetobacter baumannii and 15 of Acinetobacter genospecies 3 (AG3) were consecutively collected in a 30-day period during the nationwide project GEIH-Ab2000. Nosocomial acquisition (P = ...
Article
Icon

Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients 

Pierrotti, L. C; Pérez-Nadales, E.; Fernández-Ruiz, M.; Gutiérrez Gutiérrez, Belén; Tan, B. H.; Carratalà, J.; Cordero Matia, María Elisa; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús; Aguado, J. M. (Willey-Blackwell, 2021)
Background Whether active therapy with β-lactam/β-lactamase inhibitors (BLBLI) is as affective as carbapenems for extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) bloodstream infection (BSI) secondary ...
  • 1
  • 2
  • 3
  • 4
  • About idUS
  • Deposit your work
  • Services
  • Distribution License
  • FAQS
  • idUS in figures
Universidad de Sevilla
  • idUS is a DSpace implementation and is managed by Biblioteca de la Universidad de Sevilla.
  • Last update: 22 May 2023.
Contact  |  Help
The content of idUS is protected by Creative Commons 4.0 Internacional Licenses.
Creative Commons LicensesLevel AA conformance, W3C WAI Web Content Accessibility Guidelines 2.0Logo CrueLogo Handle
Copyright © 2015. idUS. Depósito de Investigación de la Universidad de Sevilla.
     

     

    We use cookies

    This website uses its own and third-party cookies to maintain the session, offer you a better user experience and obtain statistical data on user navigation. For more information see the Cookie Policy.